Research //

Clinical trial approved to help the NHS treat COVID-19 patients using plasma

Up to 5,000 severely ill patients with COVID-19 could soon be treated each week with plasma from those who have recovered from the illness as part of a new approach to treating the virus.<img class="alignright wp-image-135407 size-large" src="” alt=”Coronavirus” width=”360″ height=”202″ />

The national randomised clinical trial will help to determine if plasma collected from donors who have recovered from COVID-19, known as ‘convalescent plasma’, is an effective treatment for patients who are severely unwell with the illness. Plasma from recovered COVID-19 patients can be transfused to patients who are struggling to produce their own antibodies against the virus.

Continue Reading

To access this content please register.

Register for Free

Already a member? Login

Please register or login to comment!

Register now Login

Select a page to copy this section to:

Select where in the level you want it inserted: